Fingerprint
Dive into the research topics of 'Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: The ENTRANCE study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: The ENTRANCE study
K. R. Herrlinger*, M. Diculescu, K. Fellermann, H. Hartmann, S. Howaldt, R. Nikolov, A. Petrov, W. Reindl, J. M. Otte, S. Stoynov, U. Strauch, A. Sturm, R. Voiosu, A. Ammendola, B. Dietrich, B. Hentsch, E. F. Stange
*Corresponding author for this work
- Robert Bosch GmbH
- Internal Medicine I
- Asklepios Klinik St. Georg
- Elias Emergency University Hospital
- Gastroenterologische Gemeinschaftspraxis Herne
- Gastroenterologische Schwerpunktpraxis
- Clinic for Gastroenterology Sofia
- Internal Disease Department
- MHAT Tokuda Hospital Sofia EAD
- Gastroenterology
- Technical University of Munich
- Ruhr-University Bochum
- MHAT Tsaritsa Ioanna
- University of Regensburg
- Charite - Universitatsmedizin Berlin
- Colentina Clinical Hospital Bucharest
- 4SC AG
- University of Bucharest
29
Citations
(Scopus)